NO791570L - Metode for bestemmelse av kalsiumnivaaet i blod - Google Patents
Metode for bestemmelse av kalsiumnivaaet i blodInfo
- Publication number
- NO791570L NO791570L NO791570A NO791570A NO791570L NO 791570 L NO791570 L NO 791570L NO 791570 A NO791570 A NO 791570A NO 791570 A NO791570 A NO 791570A NO 791570 L NO791570 L NO 791570L
- Authority
- NO
- Norway
- Prior art keywords
- calcium
- blood
- coagulation
- edta
- added
- Prior art date
Links
- 239000011575 calcium Substances 0.000 title claims description 38
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 title claims description 36
- 229910052791 calcium Inorganic materials 0.000 title claims description 35
- 210000004369 blood Anatomy 0.000 title claims description 27
- 239000008280 blood Substances 0.000 title claims description 27
- 238000000034 method Methods 0.000 title claims description 15
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 16
- 229940071106 ethylenediaminetetraacetate Drugs 0.000 claims description 15
- 230000015271 coagulation Effects 0.000 claims description 11
- 238000005345 coagulation Methods 0.000 claims description 11
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 claims description 8
- 229910001424 calcium ion Inorganic materials 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 8
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 3
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 3
- 239000001110 calcium chloride Substances 0.000 claims description 3
- PGOHTUIFYSHAQG-LJSDBVFPSA-N (2S)-6-amino-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-4-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-1-[(2S,3R)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-4-methylsulfanylbutanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-5-carbamimidamidopentanoyl]amino]propanoyl]pyrrolidine-2-carbonyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]acetyl]amino]-3-hydroxypropanoyl]amino]-4-methylpentanoyl]amino]-3-sulfanylpropanoyl]amino]-4-methylsulfanylbutanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-hydroxybutanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-hydroxypropanoyl]amino]-3-hydroxypropanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-4-methylpentanoyl]amino]-3-hydroxybutanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-5-carbamimidamidopentanoyl]amino]-5-oxopentanoyl]amino]-3-hydroxybutanoyl]amino]-3-hydroxypropanoyl]amino]-3-carboxypropanoyl]amino]-3-hydroxypropanoyl]amino]-5-oxopentanoyl]amino]-5-oxopentanoyl]amino]-3-phenylpropanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-methylbutanoyl]amino]-4-methylpentanoyl]amino]-4-oxobutanoyl]amino]-5-carbamimidamidopentanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-4-carboxybutanoyl]amino]-5-oxopentanoyl]amino]hexanoic acid Chemical compound CSCC[C@H](N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(O)=O PGOHTUIFYSHAQG-LJSDBVFPSA-N 0.000 claims description 2
- 102000002262 Thromboplastin Human genes 0.000 claims description 2
- 108010000499 Thromboplastin Proteins 0.000 claims description 2
- 230000023555 blood coagulation Effects 0.000 claims description 2
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 claims description 2
- 239000000126 substance Substances 0.000 claims description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 1
- 240000007594 Oryza sativa Species 0.000 claims 1
- 235000007164 Oryza sativa Nutrition 0.000 claims 1
- 235000009566 rice Nutrition 0.000 claims 1
- 239000011734 sodium Substances 0.000 claims 1
- 229910052708 sodium Inorganic materials 0.000 claims 1
- 238000012360 testing method Methods 0.000 description 17
- 241000283690 Bos taurus Species 0.000 description 6
- 239000003708 ampul Substances 0.000 description 6
- 210000002966 serum Anatomy 0.000 description 4
- 208000013038 Hypocalcemia Diseases 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 238000005534 hematocrit Methods 0.000 description 2
- 230000000705 hypocalcaemia Effects 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 208000031295 Animal disease Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010028289 Muscle atrophy Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- -1 calcium chloride Chemical compound 0.000 description 1
- 230000009920 chelation Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/84—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving inorganic compounds or pH
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Inorganic Chemistry (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI781483A FI56751C (fi) | 1978-05-11 | 1978-05-11 | Foerfarande foer bestaemning av kalciumhalten i blod |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO791570L true NO791570L (no) | 1979-11-13 |
Family
ID=8511692
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO791570A NO791570L (no) | 1978-05-11 | 1979-05-10 | Metode for bestemmelse av kalsiumnivaaet i blod |
Country Status (7)
| Country | Link |
|---|---|
| AU (1) | AU4683379A (de) |
| DE (1) | DE2918335A1 (de) |
| DK (1) | DK193179A (de) |
| FI (1) | FI56751C (de) |
| FR (1) | FR2425642A1 (de) |
| NO (1) | NO791570L (de) |
| SE (1) | SE7903631L (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3671971D1 (de) * | 1985-09-05 | 1990-07-19 | Graeub Ag Ernst | Veterinaermedizinischer reagentiensatz fuer schnelltest zur bestimmung des blutcalciumgehaltes. |
| EP0325106B1 (de) * | 1988-01-05 | 1992-10-21 | Axel Dr. Linhart | Verfahren und Test-Kit zur semiquantitativen Bestimmung des Kalziumgehaltes im Blut |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2147066C3 (de) * | 1971-09-21 | 1975-02-13 | Temmler-Werke, Vereinigte Chemische Fabriken, 3550 Marburg | Verfahren und Schnelltest-Tablette zur orientierenden selektiven Schnellbestimmung von Calcium Im Harn |
-
1978
- 1978-05-11 FI FI781483A patent/FI56751C/fi not_active IP Right Cessation
-
1979
- 1979-04-25 SE SE7903631A patent/SE7903631L/ not_active Application Discontinuation
- 1979-05-07 AU AU46833/79A patent/AU4683379A/en not_active Abandoned
- 1979-05-07 DE DE19792918335 patent/DE2918335A1/de not_active Withdrawn
- 1979-05-10 DK DK193179A patent/DK193179A/da not_active Application Discontinuation
- 1979-05-10 FR FR7911857A patent/FR2425642A1/fr not_active Withdrawn
- 1979-05-10 NO NO791570A patent/NO791570L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FI56751B (fi) | 1979-11-30 |
| FR2425642A1 (fr) | 1979-12-07 |
| DK193179A (da) | 1979-11-12 |
| SE7903631L (sv) | 1979-11-12 |
| FI56751C (fi) | 1980-03-10 |
| AU4683379A (en) | 1979-11-15 |
| DE2918335A1 (de) | 1979-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Naylor | A retrospective study of the relationship between clinical signs and severity of acidosis in diarrheic calves | |
| Woodman et al. | Estimation of serum total lipids | |
| Lauwerys et al. | Characterization of cadmium proteinuria in man and rat. | |
| Cheek et al. | An appraisal of methods of tissue chloride analysis: the total carcass chloride, exchangeable chloride, potassium and water of the rat | |
| Tola | The effect of blood lead concentration, age, sex and time of exposure upon erythrocyte δ-aminolevulinic acid dehydratase activity | |
| Filipova et al. | Vitamin D insufficiency is not associated with thyroid autoimmunity in Slovak women with Hashimotos disease | |
| NO791570L (no) | Metode for bestemmelse av kalsiumnivaaet i blod | |
| Brooks | Precise titration of complement | |
| Margolis et al. | The determination of water in crude oil and transformer oil reference materials | |
| Pun et al. | Subclinical hyponatremia, hyperkalemia and hypomagnesemia in patients with poorly controlled diabetes mellitus | |
| Dubravčić | Determination of iodine in common salt by the catalytic reduction of ceric ions | |
| Belonje | Serum ionized calcium in the sheep: Relation to total plasma calcium, blood pH, total plasma proteins and plasma magnesium | |
| Denis et al. | Methods of preservation of specimens of blood intended for the determination of the nonprotein organic constituents | |
| Trinder et al. | A colorimetric method for the determination of carboxyhaemoglobin over a wide range of concentrations | |
| Clark | A study of the plasma sodium and potassium levels in normal Merino sheep | |
| Fisher et al. | Scheme for validation of an analytical protocol: semiautomated Kjeldahl nitrogen determination | |
| Gard | Method of Assay for Isopropyl N-Phenylcarbamate | |
| SU742791A1 (ru) | Способ количественного определени сульфаниламидных препаратов | |
| Keys | CCCXXXIV.—The determination of chlorides with the highest accuracy | |
| Dow et al. | Determination of the chloride content of small muscle samples | |
| JPS6314303B2 (de) | ||
| SU1047839A1 (ru) | Способ определени гексаметилентетрамина | |
| Nesterovskaya et al. | Study of the effect of seven-day immersion on the excretory function of the kidneys | |
| Caven | Quantitative chemical analysis and inorganic preparations | |
| Itai et al. | Determination of submicrogram quantities of fluoride by a rapid and highly sensitive method |